The rise of Viagra and its impact on the drug landscape presents a intricate question for investors. While the first sales data were impressive, the exclusivity has expired, leading to a flood of copycat alternatives https://nicolaslsrz880825.tribunablog.com/the-blue-pill-and-big-pharma-a-risky-bet-56062491